Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 15, 2026 08:00 ET | Source: UnitX

UnitX Launches The World's Fastest to Deploy AI Smart Camera to Bridge the Manufacturing Vision Gap

Ecosystem-agnostic edge camera deploys in 1 minute and delivers enterprise AI capabilities at cost of a basic vision sensor, enabling manufacturers to catch quality problems the moment they occur on...
June 15, 2026 08:00 ET | Source: Aerska

Aerska Strengthens Board with Appointments of Uli Stilz and Itziar Canamasas

DUBLIN and LONDON, 15 June 2026 -- Aerska, a biotechnology company using brain shuttle technology to develop RNA medicines for CNS diseases, today announces the appointment of Itziar Canamasas and Uli...
June 15, 2026 07:45 ET | Source: Asko Appliances AB

ASKO partners with the FIFA World Cup 2026™, honouring the dedication, time and dreams that define world-class performance

ASKO partners with the FIFA World Cup 2026™, honouring the dedication, time and dreams that define world-class performance.
June 15, 2026 07:30 ET | Source: Medicus Pharma Ltd

Medicus Pharma Announces U.S. Food and Drug Administration (FDA) Submission of Rare Pediatric Disease Designation Request for SkinJect® in Gorlin Syndrome

PHILADELPHIA, June 15, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development...
June 15, 2026 07:30 ET | Source: Aptose Biosciences, Inc.

Aptose Presents Safety, Response, and MRD Clinical Data from TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML at the 2026 EHA Congress in Oral Presentation

Aptose Presents Safety, Response, and MRD Clinical Data from TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML at the 2
June 15, 2026 07:27 ET | Source: Nano Dimension

Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

Nano Dimension Conducted a Rigorous Multi-Month Strategic Review, Assessing Approximately 20 Companies Before Selecting Infinite Epigenetics as the Most Compelling Path to Long-Term Value...
June 15, 2026 07:25 ET | Source: Dyadic International, Inc.

Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption

Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption
June 15, 2026 07:14 ET | Source: SNS Insider pvt ltd

Capillary Blood Collection Devices Market to Value USD 4.86 Billion by 2035, Expanding at an 8.26% CAGR – SNS Insider

Austin, United States, June 15, 2026 (GLOBE NEWSWIRE) -- “According to SNS Insider, the Capillary Blood Collection Devices Market was valued at USD 2.20 Billion in 2025 and is projected to reach USD...
June 15, 2026 07:00 ET | Source: HMNC Holding GmbH

HMNC Brain Health announces $50 million first closing of Series B financing and a strategic partnership with MEDICE

Financing will accelerate the development of HMNC’s neurosciences portfolio, including Phase 3-readiness activities for Ketabon (KET01) and Nelivabon (BH-200)Agreement grants MEDICE exclusive European...
June 15, 2026 07:00 ET | Source: Elicio Therapeutics Inc.

Elicio Therapeutics Reports Results from Phase 2 AMPLIFY-7P Study and Outlines Refined Phase 3 Development Strategy for ELI-002 7P in Adjuvant Pancreatic Cancer

AMPLIFY-7P did not meet the pre-specified primary endpoint of disease-free survival (“DFS”) in the intent-to-treat population.Randomization balanced most prognostic factors between arms. However, the...